期刊文献+

葡萄球菌和肠球菌耐药监测 被引量:2

Surveillance on Bacterial Resistance of 1779 Strains of Staphylococcus and Enterococcus
原文传递
导出
摘要 目的调查分析四川省人民医院1 779株葡萄球菌和肠球菌分布及其对常用抗菌药物的耐药性。方法采用VITEK全自动细菌鉴定仪及纸片扩散法(K-B法)进行鉴定及药物敏感性分析。结果金黄色葡萄球菌中耐甲氧西林金黄色葡萄球菌(MRSA)检出率占54.3%,未发现对万古霉素、替考拉宁和利奈唑胺的耐药株;肠球菌属中,屎肠球菌和粪肠球菌均已出现对利奈唑胺和替考拉宁耐药的菌株。结论四川省人民医院葡萄球菌和肠球菌中金黄色葡萄球菌对万古霉素、替考拉宁和利奈唑胺均敏感,但葡萄球菌和肠球菌耐药性需加强监测,并采取有效控制措施。 Objective To investigate the clinical pathogen resistance profile to antimicrobial agents of 1 779 stains of staphylococcus and enterococcus. Methods A total of 1 779 strains were identified with a Vitek -2 mcrobiology analyzer and antimierobial susceptibility testing was performed by Kirby - Bauer disk diffusion. Results Of the 1 779 clinical isolates, Methicillin resistant strains in Staphylococcus aureus (MRSA) accounted for 54.3%. None of Staphylococcus aureus isolates was found resistant to vancomycin, teicoplanin or linezolid. Among Enterococcus spp. , a few strains of E faeeium and E faecalis showed resistant to teicoplanin and linezolid. Conclusion Staphylococcus aureus were all sensitive to vancomycin, teicoplanin and linezolid. Surveillance of antimicrobial agents is in urgent demand and effective control measures are necessary.
出处 《寄生虫病与感染性疾病》 CAS 2012年第4期192-194,共3页 Parasitoses and Infectious Diseases
关键词 葡萄球菌 肠球菌 耐药监测 staphylococcus enterococcus surveillance of bacterial resistance
  • 相关文献

参考文献10

二级参考文献82

共引文献1778

同被引文献20

  • 1刘兴态,汪华,曾蓉,李玉梅.肠球菌的耐药性监测[J].实用医技杂志,2006,13(19):3404-3404. 被引量:1
  • 2Clinical and Laboratory Standards Institute (CLS1). Performancestandards for Antimicrobial Susceptibility testinj?[S]. NineteenthInformational Supplement. Clinical and Laboratory Standards In-stitute, 2009, 29(3): 100-19.
  • 3Kobaya.shi CC\ Sadoyania (;,Vieira Jl). et al. Associated anti-microbial resistance in Knterococcus spp. clinical isolates[J]. RevSoc Bras Med Trop, 2011 . 44: 341_8.
  • 4vSzymanska E. -Markuszowski M J. C'apron X. t、t al. Increasingconclusiveness of metabonomic studies by cheminformatic prepro-cessing of capillary electrophoretic data on urinary nucleoside pro-files[J]. Pharm Biomed Anal,2007,43(2) : 413 - 20.
  • 5Vergidis PI. Falagas ME. New antibiotic agents for blood streaminfectiona[J]. Int J Antimicrob Agents, 2008,32(Suppll) : 60 -5.
  • 6Koh WJ,Kwon ()J,Gwak H, et al. Daily 300 mg dose of linezol-id for the treatment of intractable multidrug. Resistant and exten-sively drag-resistant tuberculosis[J]. J Antimicrob Chemother,2009,64: 388 - 91.
  • 7Schaberg D R, Dillon W I,Terpenning M S,et al. Increasing re-sistance of enterococci to ciprofloxacin [J]. Antimicrob AgentsChemother, 1992,36( 11) : 2533 - 5.
  • 8Tankovic J,Mahjoubi F,Courvalin P, et al. Development of fluoroquinolone resistance in Enterococcus faecalis and role of mu-tations in the DNA gyrase gyrA gene [J]. Antimicrob AgentsChemother, 1996, 40(13 ) : 2558 - 61.
  • 9Sulochana S,Rahaman F,Paramasivan C N. In vitro activity offluoro-Quinolones against Mycobacterium tuberculosis [J]. J Che-mother, 2005, 17(2) : 169 - 73.
  • 10Bingjun T,Yoshida H, Yan W, et al. Molecular typing and epi-demiology of non-polio enteroviruses isolated from Yunnan Prov-ince, the People's Republic of China[J]. J Med Virol, 2008,80(40) : 670 - 9.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部